Status:
COMPLETED
Oral Progesterone for Prevention of Miscarriage in Threatened Abortion
Lead Sponsor:
Chulalongkorn University
Conditions:
Threatened Abortion
Eligibility:
FEMALE
18-45 years
Phase:
PHASE4
Brief Summary
This study evaluates the effectiveness of oral dydrogesterone in preventing miscarriage in threatened abortion. Half of participants will receive oral dydrogesterone, while the other half will receive...
Eligibility Criteria
Inclusion
- singleton pregnancy with gestational age 6 - 20 weeks
- threatened abortion
- confirmed intrauterine pregnancy with a viable fetus by ultrasound
Exclusion
- history of recurrent miscarriage
- having endocervical polyp
- having infection such as pneumonia, pyelonephritis, septicemia
- having autoimmune diseases such as systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis
- having cancer
- having coagulation defect
- allergy to dydrogesterone
Key Trial Info
Start Date :
August 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04788108
Start Date
August 1 2021
End Date
August 31 2022
Last Update
August 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Chulalongkorn University
Bangkok, Thailand, 10330